alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 7
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               JUN-30-1998
<DEBT-HELD-FOR-SALE>                           227,310
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                       6,539
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                 253,290
<CASH>                                           4,151
<RECOVER-REINSURE>                             154,797
<DEFERRED-ACQUISITION>                           5,004
<TOTAL-ASSETS>                                 515,500
<POLICY-LOSSES>                                281,126
<UNEARNED-PREMIUMS>                             50,125
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                 23,776
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           842
<OTHER-SE>                                     137,293
<TOTAL-LIABILITY-AND-EQUITY>                   515,500
<PREMIUMS>                                      34,422
<INVESTMENT-INCOME>                              7,670
<INVESTMENT-GAINS>                               1,237
<OTHER-INCOME>                                   2,997
<BENEFITS>                                      19,363
<UNDERWRITING-AMORTIZATION>                      6,095
<UNDERWRITING-OTHER>                            11,428
<INCOME-PRETAX>                                  8,709
<INCOME-TAX>                                     2,200
<INCOME-CONTINUING>                              6,509
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     6,509
<EPS-PRIMARY>                                     0.77
<EPS-DILUTED>                                     0.78
<RESERVE-OPEN>                                 139,841
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                134,081
<CUMULATIVE-DEFICIENCY>                              0
        

</TABLE>
Exhibit 32.2


              CERTIFICATION OF CHIEF FINANCIAL OFFICER
                 PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO
            SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with the IGENE Biotechnology, Inc. (the "Company")
Quarterly Report on Form 10-Q for the period ended March 31, 2010  as
filed with the Securities and Exchange Commission (the "Report"),  I,
Edward J. Weisberger, Chief Financial Officer of the Company, certify
pursuant  to 18 U.S.C. Section 1350, as adopted pursuant  to  Section
906  of  the  Sarbanes-Oxley Act of 2002, that, to  the  best  of  my
knowledge:

          (1).  The  Report  fully complies with the requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act  of
          1934, as amended; and

          (2).   The  information  contained  in  the  Report  fairly
          presents, in all material respects, the financial condition
          and results of operations of the Company.


Date: May 14, 2010                 By:  /S/ EDWARD J. WEISBERGER
                                        _____________________________
                                            EDWARD J. WEISBERGER
                                            Chief Financial Officer


A  signed original of this written statement required by Section  906
has  been provided to the Company and will be retained by the Company
and  furnished to the Securities and Exchange Commission or its staff
upon request.
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



         In  connection  with the Annual Report of Bio-Life  Labs,  Inc. on Form
10-KSB for the period  ending June 30, 2004,  as filed with the  Securities  and
Exchange Commission on the date hereof (the "Report"), I, Nancy LeMay, President
of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
to  Section  906 of the  Sarbanes-Oxley  Act of  2002,  that,  to the best of my
knowledge and belief:

         (1)      the Report fully  complies  with the  requirements  of Section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      the information  contained in the Report fairly  presents,  in
                  all material respects,  the financial  condition and result of
                  operations of the Company.


/s/    Nancy LeMay
Nancy LeMay
President, Secretary, Director
(Principal Executive Officer)


October 14, 2004


A signed  original of this written  statement  required by Section 906, or other
document authenticating, acknowledging, or otherwise adopting the signature that
appears in typed form within the  electronic  version of this written  statement
has been  provided  to the  Company  and will be  retained  by the  Company  and
furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                    10000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                   10000
<CURRENT-LIABILITIES>                                0
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           100
<OTHER-SE>                                        9900
<TOTAL-LIABILITY-AND-EQUITY>                     10000
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
#### Charles LaDUKE, Plaintiffs-Appellees, v. Alan C. NELSON, etc., et al., Defendants-Appellants.

Nos. 83-3608, 84-4148.

United States Court of Appeals, Ninth Circuit.

Aug. 7, 1986.

Michael J. Fox, Skellenger, Ginsberg & Bender, Seattle, Wash., for plaintiffs-appellees.

Marshall Tamal Golding, U.S. Dept, of Justice, Washington, D.C., for defendants-appellants.

*310Before FARRIS, ALARCON and FERGUSON, Circuit Judges.

ORDER

*LaDuke v. Nelson,*762 F.2d 1318 (9th Cir.1985), filed June 10, 1985, is modified as follows:

> The last sentence of the first full paragraph of the opinion, 762 F.2d at 1321, is changed to: “We affirm in part, vacate in part, and remand.”

> The fifth full paragraph on 762 F.2d at 1333, which begins “Finally,” is deleted. The following paragraphs are substituted:

> “Finally, the INS charges that the hourly fee award ($100 and $125) to class counsel unreasonably exceeded the normal fee of $75 per hour under the EAJA. The EAJA authorizes exceeding the $75 ‘cap’ on attorney fees based on either a cost of living increase or a ‘special factor, such as the limited availability of qualified attorneys for the proceedings.’ 28 U.S.C. § 2412(d)(2)(A)(ii). The court did not abuse its discretion in finding a special factor existed for breaching the $75 cap based on expert testimony. *Accord Action on Smoking and Health v. CAB,*724 F.2d 211, 219 (D.C.Cir.1984). Accordingly, we affirm the award of attorney’s fees and the hourly rates.

> “We vacate the district court’s use of the 20% multiplier, however, and remand the issue of the propriety of a multiplier to the district court for such further proceedings, findings, and orders as it may deem necessary in light of the recent Supreme Court decisions in *Pennsylvania v. Delaware Valley Citizens’ Council for Clean Air,*— U.S. —, 106 S.Ct. 3088, 92 L.Ed.2d 439 (1986); *Library of Congress v. Shaw,*— U.S. —, 106 S.Ct. 2957, 92 L.Ed.2d 250 (1986); *City of Riverside v. Rivera,*— U.S. —, 106 S.Ct. 2686, 91 L.Ed.2d 466 (1986).”

> Section IV. of the opinion, 762 F.2d at 1333, is changed to: “We affirm the district court’s issuance of an amended injunction and the award of fees and costs and the hourly rates, but vacate and remand the use of the 20% multiplier.”
§ 1273.6 Debt management duties of the OF. ( a ) *Issuing and servicing of consolidated obligations.* The OF, as agent for the Banks, shall issue and service (including making timely payments on principal and interest due, subject to §§ 1270.9 and 1270.10 of this chapter) consolidated obligations pursuant to and in accordance with the policies and procedures established by the OF board of directors under this part.
( b ) *Combined financial reports requirements.* The OF, under the oversight of the Audit Committee, shall prepare and distribute the combined annual and quarterly financial reports for the Bank System in accordance with the following requirements: ( 1 ) The scope, form, and content of the disclosure generally shall be consistent with the requirements of the Securities and Exchange Commission Regulations S-K and S-X (17 CFR parts 229 and 210).
( 2 ) Information about each Bank shall be presented as a segment of the Bank System as if generally accepted accounting principles regarding business segment disclosure applied to the combined annual and quarterly financial reports of the Bank System, and shall be presented using consistent accounting policies and procedures as provided in § 1273.9(b) of this part.
( 3 ) The standards set forth in paragraphs (b)(1) and (b)(2) of this section are subject to the exceptions set forth in Appendix A to this part.
( 4 ) The combined Bank System annual financial reports shall be filed with FHFA and distributed to each Bank and Bank member within 90 days after the end of the fiscal year. The combined Bank System quarterly financial reports shall be filed with FHFA and distributed to each Bank and Bank member within 45 days after the end of the of the first three fiscal quarters of each year.
( 5 ) The Audit Committee shall ensure that the combined Bank System annual or quarterly financial reports comply with the standards of this part.
( 6 ) The OF and the OF board of directors, including the Audit Committee, shall comply promptly with any directive of FHFA regarding the preparation, filing, amendment, or distribution of the combined Bank System annual or quarterly financial reports.
( 7 ) Nothing in this section shall create or be deemed to create any rights in any third party.
( c ) *Capital markets data.* The OF shall provide capital markets information concerning debt to the Banks.
( d ) *NRSROs.* The OF shall manage the relationships with NRSROs in connection with their rating of consolidated obligations.
( e ) *Research.* The OF shall conduct research reasonably related to the issuance or servicing of consolidated obligations.
( f ) *Monitor Banks' credit exposure.* The OF shall timely monitor, and compile relevant data on, each Bank's and the Bank System's unsecured credit exposure to individual counterparties.
[75 FR 23161, May 3, 2010, as amended at 81 FR 76298, Nov. 2, 2016]
Exhibit 10.19

 

A request for confidential treatment has been made with respect to portions of the following document that are marked with [*]. The redacted portions have been filed separately with the SEC.

 

First Amendment to Development and Manufacturing Services Agreement

 

This first amendment to the DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (hereinafter referred to as the “First Amendment”) is entered into between the QuaDPharma, LLC, a Delaware Limited Liability Company (“QuaDPharma”); and Anterios, Inc., a Delaware corporation, with offices located at 60 East 42nd St, New York, New York 10165 (“Anterios”); and is made as of April 23, 2015.

 

Background

 

Anterios and QuaDPharma are parties to a DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT that was effective August 17, 2011 (the “Services Agreement”).

 

Anterios and QuaDPharma desire to amend the Services Agreement to extend the agreement.

 

Therefore, Anterios and QuaDPharma hereby agree as follows:

 

I              Paragraph 14.1 of the Services Agreement, “Term,” is replaced in its entirety with the following:

 

Term. This Agreement will take effect as of the Effective Date and, unless earlier terminated pursuant to this Section 14, will expire on the later of (a) [*], or (b) the completion of Services under the last Work Order executed by the parties prior to the [*] anniversary of the Effective Date. The term of this Agreement may be extended continuously for additional [*] year periods upon mutual written agreement at least [*] prior to the expiration of the then current term.

 

IN WITNESS WHEREOF, the parties hereto have duly executed this First Amendment effective as of the date first above written.

 

 

	
QUADPHARMA, LLC
    	
ANTERIOS, INC.
    
	
 
    	
 
    
	
By:
    	
/s/ Stephen A. Panaro, Ph.D.
    	
 
    	
By:
    	
/s/ Jon Edelson, MD
    
	
Name:
    	
Stephen A. Panar, Ph.D
    	
 
    	
Name:
    	
Jon Edelson, MD
    
	
Title:
    	
President & COO
    	
 
    	
Title:
    	
CEO & President
    


 

	
Date:
    	
04/24/2015
    	
 
    	
Date:
    	
4/25/2015
§ 1260.2 Bank information to be shared. ( a ) *General.* In order to enable each Bank to evaluate the financial condition of any one or more of the other Banks and the Bank System, FHFA shall distribute to each Bank and to the Office of Finance, or shall require each Bank to distribute directly to each other Bank and the Office of Finance, such categories of financial and supervisory information regarding each Bank and the Bank system as it determines to be appropriate, subject to the requirements of this part.
( b ) *Notice.* FHFA shall prepare and issue to each Bank and the Office of Finance a notice setting forth the categories of information to be distributed, which it shall review from time to time and revise as necessary to ensure that the information distributed remains useful to the Banks in evaluating the financial strength of the other Banks and the Bank System. Prior to issuing a new or revised notice, FHFA shall notify each Bank and the Office of Finance of its proposed contents and allow them a reasonable period within which to comment.
( c ) *Director's orders.* The Director or his designee may issue such orders as are necessary to effect the distribution of the information set forth in the notice issued under paragraph (b) of this section and to carry out the provisions of this part.
§ 21.8074 Computing the period for vocational training program participation. ( a ) *Computing the participation period.* To compute the number of months and days of an eligible child's participation in a vocational training program: ( 1 ) Count the number of actual months and days of the child's: ( i ) Pursuit of vocational education or training;
( ii ) Receipt of extended evaluation-type services and training, or services and training to enable the child to prepare for vocational training or employment, if a veteran in a 38 U.S.C. chapter 31 program would have received a subsistence allowance while receiving the same type of services and training; and
( iii ) Receipt of employment and post-employment services (any period of employment or post-employment services is considered full-time program pursuit).
( 2 ) Do not count: ( i ) The initial evaluation period;
( ii ) Any period before the child enters a vocational training program under this subpart;
( iii ) Days of authorized leave; and
( iv ) Other periods during which the child does not pursue training, such as periods between terms.
( 3 ) Convert part-time training periods to full-time equivalents.
( 4 ) Total the months and days under paragraphs (a)(1) and (a)(3) of this section. This sum is the period of the child's participation in the program. (Authority: 38 U.S.C. 1804(d), 1814)
( b ) *Consistency with principles for charging entitlement.* Computation of the program participation period under this section will be consistent with the principles for charging entitlement under § 21.8020.
(Authority: 38 U.S.C. 1804(d), 1814)
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
Financial Data Sheet for NHP Retirement Housing Partners I, L.P.
</LEGEND>
<CIK>                         0000793730
<NAME>                        NHP Retirement Housing Partners I, L.P.
<MULTIPLIER>                  1
<CURRENCY>                    U.S. Dollars
       
<S>                             <C>
<PERIOD-TYPE>                 3-MOS
<FISCAL-YEAR-END>             DEC-31-1998
<PERIOD-START>                JAN-01-1998
<PERIOD-END>                  MAR-31-1998
<EXCHANGE-RATE>               1
<CASH>                        5,037,402
<SECURITIES>                  0
<RECEIVABLES>                 21,481
<ALLOWANCES>                  0
<INVENTORY>                   0
<CURRENT-ASSETS>              0
<PP&E>                        65,091,025
<DEPRECIATION>                (15,890,210)
<TOTAL-ASSETS>                55,760,173
<CURRENT-LIABILITIES>         0
<BONDS>                       42,672,000
<PREFERRED-MANDATORY>         0
<PREFERRED>                   0
<COMMON>                      0
<OTHER-SE>                    (12,740,725)
<TOTAL-LIABILITY-AND-EQUITY>  55,760,173
<SALES>                       0
<TOTAL-REVENUES>              4,115,035
<CGS>                         0
<TOTAL-COSTS>                 3,089,412
<OTHER-EXPENSES>              148,015
<LOSS-PROVISION>              0
<INTEREST-EXPENSE>            1,582,983
<INCOME-PRETAX>               (705,375)
<INCOME-TAX>                  0
<INCOME-CONTINUING>           0
<DISCONTINUED>                0
<EXTRAORDINARY>               0
<CHANGES>                     0
<NET-INCOME>                  (705,375)
<EPS-PRIMARY>                 0
<EPS-DILUTED>                 0
        



</TABLE>
#### § 150.310 What if the FDIC does not insure the deposits?

If the FDIC does not insure the entire amount of a self deposit, you must set aside collateral as security. If the FDIC does not insure the entire amount of an affiliate deposit, you or your affiliate must set aside collateral as security. The market value of the collateral must at all times equal or exceed the amount of the uninsured fiduciary funds. You must place the collateral under the control of appropriate fiduciary officers and employees.
§ 17.49 Priorities for outpatient medical services and inpatient hospital care. In scheduling appointments for outpatient medical services and admissions for inpatient hospital care, the Under Secretary for Health shall give priority to: ( a ) Veterans with service-connected disabilities rated 50 percent or greater based on one or more disabilities or unemployability; and
( b ) Veterans needing care for a service-connected disability.
(Authority: 38 U.S.C. 101, 501, 1705, 1710)
[67 FR 58529, Sept. 17, 2002]
Order entered October 8, 2014

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05 - 14 - 00146 - CR ESSIE D. HOPKINS, Appellant

V. THE STATE OF TEXAS, Appellee On Appeal from the 291st Judicial District Court

Dallas County, Texas Trial Cour t Cause No. F 13 - 55764 - U



### O RDER Appellant’s October 6, 2014 motion to extend the time to file appellant’s brief is GRANTED . The time to file appellant’s brief is EXTENDED to November 4, 2014

. /s/ LANA MYERS JUSTICE
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS FOR DECEMBER 31, 1998 AND FOR JUNE 30, 1999 AS FILED ON
FORMS 10KSB AND 10QSB WITH THE SECURITIES AND EXCHANGE COMMISSION AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                          54,673
<SECURITIES>                                         0
<RECEIVABLES>                                  449,640
<ALLOWANCES>                                    20,000
<INVENTORY>                                    229,606
<CURRENT-ASSETS>                               745,930
<PP&E>                                         138,947
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 967,575
<CURRENT-LIABILITIES>                        1,557,445
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                    500,000
<COMMON>                                    13,817,844
<OTHER-SE>                                (15,089,714)
<TOTAL-LIABILITY-AND-EQUITY>                   967,575
<SALES>                                        883,867
<TOTAL-REVENUES>                               883,867
<CGS>                                          522,448
<TOTAL-COSTS>                                  522,448
<OTHER-EXPENSES>                               716,913
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              18,000
<INCOME-PRETAX>                              (373,494)
<INCOME-TAX>                                 (373,494)
<INCOME-CONTINUING>                          (373,494)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (373,494)
<EPS-BASIC>                                      (.08)
<EPS-DILUTED>                                    (.08)


</TABLE>